Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9742933rdf:typepubmed:Citationlld:pubmed
pubmed-article:9742933lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9742933lifeskim:mentionsumls-concept:C0085828lld:lifeskim
pubmed-article:9742933lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:9742933lifeskim:mentionsumls-concept:C0282549lld:lifeskim
pubmed-article:9742933lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:9742933lifeskim:mentionsumls-concept:C1537647lld:lifeskim
pubmed-article:9742933lifeskim:mentionsumls-concept:C0086860lld:lifeskim
pubmed-article:9742933lifeskim:mentionsumls-concept:C1149208lld:lifeskim
pubmed-article:9742933pubmed:issue3lld:pubmed
pubmed-article:9742933pubmed:dateCreated1998-10-8lld:pubmed
pubmed-article:9742933pubmed:abstractTextInterleukin-5 (IL-5) plays a crucial role in the proliferation, differentiation and activation of eosinophils. The IL-5 receptor is composed of an IL-5-specific alpha subunit, which is expressed by eosinophils and basophils, and a beta c-subunit shared with the receptors for IL-3 and GM-CSF. We identified an AP-1 element which is important for IL-5R alpha promoter activity in eosinophilic HL60 cells. The AP-1 site and the previously identified EOS1 site cooperate, since single mutation of either of the sites decreased promoter activity. We show that the AP-1 site of the IL-5R alpha promoter binds multiple proteins, including cJun, CREB, and CREM.lld:pubmed
pubmed-article:9742933pubmed:languageenglld:pubmed
pubmed-article:9742933pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9742933pubmed:citationSubsetIMlld:pubmed
pubmed-article:9742933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9742933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9742933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9742933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9742933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9742933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9742933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9742933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9742933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9742933pubmed:statusMEDLINElld:pubmed
pubmed-article:9742933pubmed:monthSeplld:pubmed
pubmed-article:9742933pubmed:issn0014-5793lld:pubmed
pubmed-article:9742933pubmed:authorpubmed-author:LammersJ WJWlld:pubmed
pubmed-article:9742933pubmed:authorpubmed-author:RaaijmakersJ...lld:pubmed
pubmed-article:9742933pubmed:authorpubmed-author:ZandersEElld:pubmed
pubmed-article:9742933pubmed:authorpubmed-author:de GrootR PRPlld:pubmed
pubmed-article:9742933pubmed:authorpubmed-author:KoendermanLLlld:pubmed
pubmed-article:9742933pubmed:authorpubmed-author:van DijkT BTBlld:pubmed
pubmed-article:9742933pubmed:authorpubmed-author:CaldenhovenEElld:pubmed
pubmed-article:9742933pubmed:authorpubmed-author:BaltusBBlld:pubmed
pubmed-article:9742933pubmed:issnTypePrintlld:pubmed
pubmed-article:9742933pubmed:day4lld:pubmed
pubmed-article:9742933pubmed:volume434lld:pubmed
pubmed-article:9742933pubmed:ownerNLMlld:pubmed
pubmed-article:9742933pubmed:authorsCompleteYlld:pubmed
pubmed-article:9742933pubmed:pagination251-4lld:pubmed
pubmed-article:9742933pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:9742933pubmed:meshHeadingpubmed-meshheading:9742933-...lld:pubmed
pubmed-article:9742933pubmed:meshHeadingpubmed-meshheading:9742933-...lld:pubmed
pubmed-article:9742933pubmed:meshHeadingpubmed-meshheading:9742933-...lld:pubmed
pubmed-article:9742933pubmed:meshHeadingpubmed-meshheading:9742933-...lld:pubmed
pubmed-article:9742933pubmed:meshHeadingpubmed-meshheading:9742933-...lld:pubmed
pubmed-article:9742933pubmed:meshHeadingpubmed-meshheading:9742933-...lld:pubmed
pubmed-article:9742933pubmed:meshHeadingpubmed-meshheading:9742933-...lld:pubmed
pubmed-article:9742933pubmed:meshHeadingpubmed-meshheading:9742933-...lld:pubmed
pubmed-article:9742933pubmed:meshHeadingpubmed-meshheading:9742933-...lld:pubmed
pubmed-article:9742933pubmed:meshHeadingpubmed-meshheading:9742933-...lld:pubmed
pubmed-article:9742933pubmed:meshHeadingpubmed-meshheading:9742933-...lld:pubmed
pubmed-article:9742933pubmed:meshHeadingpubmed-meshheading:9742933-...lld:pubmed
pubmed-article:9742933pubmed:meshHeadingpubmed-meshheading:9742933-...lld:pubmed
pubmed-article:9742933pubmed:meshHeadingpubmed-meshheading:9742933-...lld:pubmed
pubmed-article:9742933pubmed:meshHeadingpubmed-meshheading:9742933-...lld:pubmed
pubmed-article:9742933pubmed:meshHeadingpubmed-meshheading:9742933-...lld:pubmed
pubmed-article:9742933pubmed:year1998lld:pubmed
pubmed-article:9742933pubmed:articleTitleAn AP-1 site in the promoter of the human IL-5R alpha gene is necessary for promoter activity in eosinophilic HL60 cells.lld:pubmed
pubmed-article:9742933pubmed:affiliationDepartment of Pulmonary Diseases, University Hospital Utrecht, The Netherlands.lld:pubmed
pubmed-article:9742933pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9742933pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9742933lld:pubmed